Found: 14
Select item for more details and to access through your institution.
Exenatide elicits sustained glycaemic control and progressive reduction of body weight in patients with type 2 diabetes inadequately controlled by sulphonylureas with or without metformin.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2006, v. 22, n. 6, p. 483, doi. 10.1002/dmrr.646
- By:
- Publication type:
- Article
Pramlintide reduces postprandial glucose excursions when added to insulin lispro in subjects with type 2 diabetes: a dose-timing study.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2004, v. 20, n. 1, p. 55, doi. 10.1002/dmrr.419
- By:
- Publication type:
- Article
Striking Differences in Glucose and Lactate Levels Between Brain Extracellular Fluid and Plasma in Conscious Human Subjects: Effects of Hyperglycemia and Hypoglycemia.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2002, v. 22, n. 3, p. 271, doi. 10.1097/00004647-200203000-00004
- By:
- Publication type:
- Article
Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus.
- Published in:
- Annals of Internal Medicine, 1998, v. 128, n. 3, p. 176, doi. 10.7326/0003-4819-128-3-199802010-00002
- By:
- Publication type:
- Article
Effects of Pramlintide on Postprandial Glucose Excursions and Measures of Oxidative Stress in Patients With Type 1 Diabetes.
- Published in:
- Diabetes Care, 2005, v. 28, n. 3, p. 632, doi. 10.2337/diacare.28.3.632
- By:
- Publication type:
- Article
Pramlintide reduces postprandial glucose excursions when added to regular insulin or insulin lispro in subjects with type 1 diabetes: a dose-timing study.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes: a 1-year randomized controlled trial.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Impact of pramlintide on glucose fluctuations and postprandial glucose, glucagon, and triglyceride excursions among patients with type 1 diabetes intensively treated with insulin pumps.
- Published in:
- 2003
- By:
- Publication type:
- journal article
A Randomized Study and Open-Label Extension Evaluating the Long-Term Efficacy of Pramlintide as an Adjunct to Insulin Therapy in Type 1 Diabetes.
- Published in:
- Diabetes Care, 2002, v. 25, n. 4, p. 724, doi. 10.2337/diacare.25.4.724
- By:
- Publication type:
- Article
Amylin Replacement With Pramlintide in Type 1 and Type 2 Diabetes: A Physiological Approach to Overcome Barriers With Insulin Therapy.
- Published in:
- Clinical Diabetes, 2002, v. 20, n. 3, p. 137, doi. 10.2337/diaclin.20.3.137
- By:
- Publication type:
- Article
Incretin-based therapies.
- Published in:
- Journal of Diabetes, 2012, v. 4, n. 1, p. 55, doi. 10.1111/j.1753-0407.2011.00143.x
- By:
- Publication type:
- Article
Counterregulation in Peripheral Tissues.
- Published in:
- Diabetes, 1997, v. 46, n. 1, p. 70, doi. 10.2337/diab.46.1.70
- By:
- Publication type:
- Article
Effect of Pramlintide on Weight in Overweight and Obese Insulin-Treated Type 2 Diabetes Patients<sup>**</sup>.
- Published in:
- Obesity (19307381), 2004, v. 12, n. 4, p. 661, doi. 10.1038/oby.2004.76
- By:
- Publication type:
- Article
Impact of Disease Duration on the Effects of Pramlintide in Type 1 Diabetes: A Post Hoc Analysis of Three Clinical Trials.
- Published in:
- 2016
- By:
- Publication type:
- journal article